Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children

Moreews, Marion; Le Gouge, Kenz; Khaldi-Plassart, Samira; Pescarmona, Rémi; Mathieu, Anne-Laure; Malcus, Christophe; Djebali, Sophia; Bellomo, Alicia; Dauwalder, Olivier; Perret, Magali; Villard, Marine; Chopin, Emilie; Rouvet, Isabelle; Vandenesh, Francois; Dupieux, Céline; Pouyau, Robin; Teyssedre, Sonia; Guerder, Margaux; Louazon, Tiphaine; Moulin-Zinsch, Anne; Duperril, Marie; Patural, Hugues; Giovannini-Chami, Lisa; Portefaix, Aurélie; Kassai, Behrouz; Venet, Fabienne; Monneret, Guillaume; Lombard, Christine; Flodrops, Hugues; De Guillebon, Jean-Marie; Bajolle, Fanny; Launay, Valérie; Bastard, Paul; Zhang, Shen-Ying; Dubois, Valérie; Thaunat, Olivier; Richard, Jean-Christophe; Mezidi, Mehdi; Allatif, Omran; Saker, Kahina; Dreux, Marlène; Abel, Laurent; Casanova, Jean-Laurent; Marvel, Jacqueline; Trouillet-Assant, Sophie; Klatzmann, David; Walzer, Thierry; Mariotti-Ferrandiz, Encarnita; Javouhey, Etienne; Belot, Alexandre

Multiple Inflammatory Syndrome in Children (MIS-C) is a delayed and severe complication of SARS-CoV-2 infection that strikes previously healthy children. As MIS-C combines clinical features of Kawasaki disease and Toxic Shock Syndrome (TSS), we aimed to compare the immunological profile of pediatric patients with these different conditions. We analyzed blood cytokine expression, and the T cell repertoire and phenotype in 36 MIS-C cases, which were compared to 16 KD, 58 TSS, and 42 COVID-19 cases. We observed an increase of serum inflammatory cytokines (IL-6, IL-10, IL-18, TNF-α, IFNγ, CD25s, MCP1, IL-1RA) in MIS-C, TSS and KD, contrasting with low expression of HLA-DR in monocytes. We detected a specific expansion of activated T cells expressing the Vß21.3 T cell receptor ß chain variable region in both CD4 and CD8 subsets in 75% of MIS-C patients and not in any patient with TSS, KD, or acute COVID-19; this correlated with the cytokine storm detected. The T cell repertoire returned to baseline within weeks after MIS-C resolution. Vß21.3+ T cells from MIS-C patients expressed high levels of HLA-DR, CD38 and CX3CR1 but had weak responses to SARS-CoV-2 peptides in vitro. Consistently, the T cell expansion was not associated with specific classical HLA alleles. Thus, our data suggested that MIS-C is characterized by a polyclonal Vß21.3 T cell expansion not directed against SARS-CoV-2 antigenic peptides, which is not seen in KD, TSS and acute COVID-19.